Nivolumab maintenance in high-risk acute myeloid leukemia patients: a single-arm, open-label, phase II study

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Article number60
JournalBlood cancer journal
Volume11
Issue number3
DOIs
StatePublished - Mar 2021

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this